Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
Clinical trial NCT04639960 · TERMINATED
Trial details
- NCT number
- NCT04639960
- Sponsor
- University of Geneva, Switzerland
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2021-05-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.